Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > SO IM MISSING THE GOOD NEWS

<< Previous

Bullboard Posts

Next >>

Comment by menoalittleon Aug 13, 2024 4:56pm

181 Views

Post# 36177365

RE:RE:RE:RE:RE:RE:RE:RE:SO IM MISSING THE GOOD NEWS

So, here's a question for anyone with a reasonably good sense of how things can or might go with possible designations and approvals for the intravesicular use of TLD-1433 with NMIBC...

How quickly can or might TLD-1433 be adapted and approved for similar use on colon cancer? I'm inclined to think (or at least, would like to believe and hope) that it ought to be much quicker and easier to at least be able to use it for this on a "right to try" basis for colomn cancer, if nothing else, given its remarkable safety factor and outstanding results with bladder cancer.

What say some of you experts out there?

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?